SCHEMBL6505870

SCHEMBL6505870

[CH2][CH]N(CC)CCCC#Cc1ccc2c(-c3ccc(C(F)(F)F)cc3)nsc2c1

nearest known ligand 0.56

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LSS P48449 11/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5035559 0.86 LSS (0.58) LSS
SCHEMBL5035560 0.85 LSS (0.78) LSS
SCHEMBL5038994 0.84 LSS (0.52) LSS
SCHEMBL5038562 0.84 LSS (0.55) LSS
SCHEMBL7167049 0.84 LSS (0.56) LSS
SCHEMBL5038349 0.83 LSS (0.61) LSS
SCHEMBL5038924 0.82 LSS (0.56) LSS
SCHEMBL5038915 0.81 LSS (0.69) LSS
SCHEMBL5040354 0.81 LSS (0.58) LSS
SCHEMBL5038931 0.80 LSS (0.52) LSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6951879-B2 Substituted benzo(b)thiophenes or benzoisothiazoles which inhibit 2,3-oxidosqualene-lanosterol cyclase which is required for the biosynthesis of cholesterol, ergosterol and other sterols HOFFMANN-LA ROCHE INC. (US) 2005-10-04 US disclosed